Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAJIV PERINBASEKAR

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1801281738
CMS profile
10357761
Location
CARMEL, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$1,003.16

64 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,003.16 64

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 64 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAJIV PERINBASEKAR

NPI 1801281738 · CMS profile ID 10357761

Allopathic & Osteopathic Physicians / Internal Medicine

CARMEL, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 64 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1801281738?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAJIV PERINBASEKAR, NPI 1801281738, CMS profile ID 10357761. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 64 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1801281738?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). RAJIV PERINBASEKAR, NPI 1801281738, CMS profile ID 10357761. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 64 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1801281738?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
RAJIV PERINBASEKAR, NPI 1801281738, CMS profile ID 10357761, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 64 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1801281738?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

64 matching records · $1,003.16 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 64 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 64.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celgene Corporation $15.4912/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381617 CMS
Celgene Corporation $1.2312/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381623 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.7611/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996407125 CMS
Celgene Corporation $16.3211/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381581 CMS
Braintree Laboratories, Inc. $15.3011/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006459877 CMS
ABBVIE INC. $17.7111/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124439 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.5011/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055539263 CMS
ABBVIE INC. $26.2711/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124437 CMS
Celgene Corporation $3.6810/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381561 CMS
Novo Nordisk Inc $24.3410/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003061307 CMS
ABBVIE INC. $13.9510/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124435 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.2110/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055539257 CMS
Celgene Corporation $17.0210/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381537 CMS
Ironwood Pharmaceuticals, Inc $20.1110/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045517017 CMS
Braintree Laboratories, Inc. $14.8010/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006459869 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.1809/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057116103 CMS
Celgene Corporation $17.7309/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381485 CMS
Celgene Corporation $1.0609/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381491 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.2209/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055539251 CMS
NESTLE HEALTHCARE NUTRITION INC. $19.0708/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012511687 CMS
ABBVIE INC. $13.0508/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124433 CMS
ABBVIE INC. $19.5008/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124431 CMS
Celgene Corporation $14.6408/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381469 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.8508/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057302683 CMS
Ardelyx, Inc. $20.0608/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052958161 CMS
Celgene Corporation $16.8908/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381457 CMS
Celgene Corporation $0.9408/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381463 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.5408/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055539245 CMS
ABBVIE INC. $17.9607/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124429 CMS
Braintree Laboratories, Inc. $19.0007/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006459861 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $9.6407/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057132723 CMS
Celgene Corporation $17.7307/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381453 CMS
Celgene Corporation $11.3006/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381447 CMS
ABBVIE INC. $14.6206/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124427 CMS
Novo Nordisk Inc $24.9606/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003061319 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $12.4506/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057356945 CMS
Celgene Corporation $17.7306/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381441 CMS
ABBVIE INC. $15.8906/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124425 CMS
ABBVIE INC. $16.0906/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124423 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.8605/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057443949 CMS
Micro-tech Endoscopy USA, Inc. $2.3005/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987662277 CMS
Ironwood Pharmaceuticals, Inc $14.5905/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045560881 CMS
ABBVIE INC. $21.0904/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124421 CMS
Merck Sharp & Dohme LLC $14.6804/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048275909 CMS
Celgene Corporation $15.7304/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381367 CMS
ABBVIE INC. $12.3304/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124419 CMS
Ardelyx, Inc. $23.3703/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052958159 CMS
Celgene Corporation $14.7803/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381355 CMS
Celgene Corporation $0.5003/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016381361 CMS
ABBVIE INC. $16.7703/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998124417 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $462.50 25
PY2022 $1,647.49 84
PY2023 $1,003.16 64
PY2024 $647.86 30
PY2025 $701.31 28

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $57,400.00 8

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $4,000.00 12/22/2025 Non-covered Recipient Entity
THE CLINICAL TRIALS NETWORK LLC
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting (PANORAMA) No dispute reported 06/30/2026 1223290044
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,000.00 12/22/2025 Non-covered Recipient Entity
THE CLINICAL TRIALS NETWORK LLC
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting (PANORAMA) No dispute reported 06/30/2026 1223290066
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,500.00 12/22/2025 Non-covered Recipient Entity
THE CLINICAL TRIALS NETWORK LLC
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting (PANORAMA) No dispute reported 06/30/2026 1223290068
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $750.00 12/22/2025 Non-covered Recipient Entity
THE CLINICAL TRIALS NETWORK LLC
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting (PANORAMA) No dispute reported 06/30/2026 1223290070
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $12,750.00 12/22/2025 Non-covered Recipient Entity
THE CLINICAL TRIALS NETWORK LLC
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting (PANORAMA) No dispute reported 06/30/2026 1223290072
Principal investigator 1 Janssen Research & Development, LLC $15,200.00 11/24/2025 Non-covered Recipient Entity
THE CLINICAL TRIALS NETWORK LLC
A Phase 3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol in Adults with an Open Label Study in Adolescents to Evaluate the Efficacy and Safety of Induction and Maintenance Therapy with Icotrokinra in Participants With Moderately to Severely Active Ulcerative Colitis ICONIC-UC No dispute reported 06/30/2026 1175373368
Principal investigator 1 Janssen Research & Development, LLC $5,000.00 11/20/2025 Non-covered Recipient Entity
THE CLINICAL TRIALS NETWORK LLC
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease No dispute reported 06/30/2026 1175373422
Principal investigator 1 Janssen Research & Development, LLC $15,200.00 11/17/2025 Non-covered Recipient Entity
THE CLINICAL TRIALS NETWORK LLC
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease No dispute reported 06/30/2026 1175373404